OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency

Obsessive-compulsive disorder (OCD) is a common neuropsychiatric disease affecting about 2% of the general population. It is characterized by persistent intrusive thoughts and repetitive ritualized behaviors. While gene variations, malfunction of cortico-striato-thalamo-cortical (CSTC) circuits, and dysregulated synaptic transmission have been implicated in the pathogenesis of OCD, the underlying mechanisms remain largely unknown. Here we show that OCD-like behavior in mice is caused by deficiency of SPRED2, a protein expressed in various brain regions and a potent inhibitor of Ras/ERK-MAPK signaling. Excessive self-grooming, reflecting OCD-like behavior in rodents, resulted in facial skin lesions in SPRED2 knockout (KO) mice. This was alleviated by treatment with the selective serotonin reuptake inhibitor fluoxetine. In addition to the previously suggested involvement of cortico-striatal circuits, electrophysiological measurements revealed altered transmission at thalamo-amygdala synapses and morphological differences in lateral amygdala neurons of SPRED2 KO mice. Changes in synaptic function were accompanied by dysregulated expression of various pre- and postsynaptic proteins in the amygdala. This was a result of altered gene transcription and triggered upstream by upregulated tropomyosin receptor kinase B (TrkB)/ERK-MAPK signaling in the amygdala of SPRED2 KO mice. Pathway overactivation was mediated by increased activity of TrkB, Ras, and ERK as a specific result of SPRED2 deficiency and not elicited by elevated brain-derived neurotrophic factor levels. Using the MEK inhibitor selumetinib, we suppressed TrkB/ERK-MAPK pathway activity in vivo and reduced OCD-like grooming in SPRED2 KO mice. Altogether, this study identifies SPRED2 as a promising new regulator, TrkB/ERK-MAPK signaling as a novel mediating mechanism, and thalamo-amygdala synapses as critical circuitry involved in the pathogenesis of OCD.

[1]  S. Rauch,et al.  Obsessive-compulsive disorder phenotypes: implications for genetic studies , 2005, Molecular Psychiatry.

[2]  J. Flint,et al.  Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice , 2008, Molecular Psychiatry.

[3]  Paul D. Smith,et al.  MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model , 2015, Molecular Cancer Therapeutics.

[4]  S. Temple,et al.  Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure. , 2010, Genes & development.

[5]  Dan J Stein,et al.  The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication , 2010, Molecular Psychiatry.

[6]  M. Kubo,et al.  Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness , 2005, The Journal of experimental medicine.

[7]  M. Adler.  Diagnostic and Statistical Manual of Mental Disorders, 4th Edition , 2016 .

[8]  J. R. Baker,et al.  Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[9]  M. Bennett,et al.  Stress and trauma: BDNF control of dendritic-spine formation and regression , 2014, Progress in Neurobiology.

[10]  D. Stein,et al.  Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD) , 2008, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[11]  K. Tye,et al.  From circuits to behaviour in the amygdala , 2015, Nature.

[12]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.

[13]  S. Dudek,et al.  Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice , 2007, Nature.

[14]  Hyejin Kang,et al.  Translational Control by MAPK Signaling in Long-Term Synaptic Plasticity and Memory , 2004, Cell.

[15]  Nils Z. Borgesius,et al.  Spred1 Is Required for Synaptic Plasticity and Hippocampus-Dependent Learning , 2008, The Journal of Neuroscience.

[16]  Huitu Liu,et al.  MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.

[17]  D. Murphy,et al.  Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[18]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[19]  Edward T Bullmore,et al.  Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review , 2010, Neuropsychopharmacology.

[20]  B. Aouizerate,et al.  Pathophysiology of obsessive–compulsive disorder A necessary link between phenomenology, neuropsychology, imagery and physiology , 2004, Progress in Neurobiology.

[21]  J. J. Couey,et al.  Postsynaptic TrkB signaling has distinct roles in spine maintenance in adult visual cortex and hippocampus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Sommer,et al.  Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice , 2010, Molecular pain.

[23]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[24]  K. Lesch,et al.  Serotonin transporter knockout and repeated social defeat stress: Impact on neuronal morphology and plasticity in limbic brain areas , 2011, Behavioural Brain Research.

[25]  M. Salamero,et al.  Obsessive-compulsive disorder in childhood and adolescence: a clinical study. , 1992, Journal of child psychology and psychiatry, and allied disciplines.

[26]  Ann M Graybiel,et al.  Toward a Neurobiology of Obsessive-Compulsive Disorder , 2000, Neuron.

[27]  S. Rauch,et al.  Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways , 2012, Trends in Cognitive Sciences.

[28]  Markus S. Schröder,et al.  Bassoon Specifically Controls Presynaptic P/Q-type Ca2+ Channels via RIM-Binding Protein , 2014, Neuron.

[29]  Alcino J. Silva,et al.  Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning , 2008, Cell.

[30]  Stephan J. Sigrist,et al.  Bruchpilot Promotes Active Zone Assembly, Ca2+ Channel Clustering, and Vesicle Release , 2006, Science.

[31]  T. Südhof.  The Presynaptic Active Zone , 2012, Neuron.

[32]  Bruce S. McEwen,et al.  Stress, memory and the amygdala , 2009, Nature Reviews Neuroscience.

[33]  G. Thomas,et al.  Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype , 2007, Nature Genetics.

[34]  Gerald M Edelman,et al.  Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[36]  E. Benarroch.  Metabotropic glutamate receptors , 2008, Neurology.

[37]  K. Lesch,et al.  Gene–environment interaction influences anxiety-like behavior in ethologically based mouse models , 2011, Behavioural Brain Research.

[38]  G. Guy,et al.  Sprouty-related Ena/Vasodilator-stimulated Phosphoprotein Homology 1-Domain-containing Protein (SPRED1), a Tyrosine-Protein Phosphatase Non-receptor Type 11 (SHP2) Substrate in the Ras/Extracellular Signal-regulated Kinase (ERK) Pathway* , 2011, The Journal of Biological Chemistry.

[39]  Shahin Rafii,et al.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice , 2010, Nature Medicine.

[40]  S. Taylor,et al.  Molecular genetics of obsessive–compulsive disorder: a comprehensive meta-analysis of genetic association studies , 2013, Molecular Psychiatry.

[41]  G. Linette,et al.  Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. , 2014, JAMA.

[42]  U. Walter,et al.  Getting a first clue about SPRED functions , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[43]  K. Knobeloch,et al.  Tissue-specific Spred-2 promoter activity characterized by a gene trap approach. , 2006, Gene expression patterns : GEP.

[44]  N. Corcoran,et al.  Distinct requirements for the Sprouty domain for functional activity of Spred proteins. , 2005, The Biochemical journal.

[45]  K. Schuh,et al.  Gene trap: knockout on the fast lane. , 2009, Methods in molecular biology.

[46]  R. Malenka,et al.  Destabilization of the Postsynaptic Density by PSD-95 Serine 73 Phosphorylation Inhibits Spine Growth and Synaptic Plasticity , 2008, Neuron.

[47]  A. El-Husseini,et al.  Excitation Control: Balancing PSD-95 Function at the Synapse , 2008, Frontiers in molecular neuroscience.

[48]  E. Bullmore,et al.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited , 2008, Neuroscience & Biobehavioral Reviews.

[49]  J. Medina,et al.  ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. , 2004, Learning & memory.

[50]  M. Dresler,et al.  Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. , 2007, Journal of psychiatric research.

[51]  K. Deisseroth,et al.  Repeated Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior , 2013, Science.

[52]  J. González,et al.  Extensive Genotyping of the BDNF and NTRK2 Genes Define Protective Haplotypes Against Obsessive-Compulsive Disorder , 2008, Biological Psychiatry.

[53]  A. Nykjaer,et al.  Loss of BDNF or its receptors in three mouse models has unpredictable consequences for anxiety and fear acquisition. , 2013, Learning & memory.

[54]  D. Joel,et al.  Current animal models of obsessive compulsive disorder: an update , 2012, Neuroscience.

[55]  Michael Davis,et al.  The amygdala: vigilance and emotion , 2001, Molecular Psychiatry.

[56]  E. Hollander,et al.  Is obsessive–compulsive disorder an anxiety disorder? , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[57]  L. Monteggia,et al.  Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders , 2012, Pharmacological Reviews.

[58]  M. Hascöet,et al.  The mouse light/dark box test. , 2003, European journal of pharmacology.

[59]  Songshu Meng,et al.  Tyrosines 303/343/353 within the Sprouty-related domain of Spred2 are essential for its interaction with p85 and inhibitory effect on Ras/ERK activation. , 2012, The international journal of biochemistry & cell biology.

[60]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[61]  G. Yancopoulos,et al.  Identification of in vivo brain-derived neurotrophic factor-stimulated autophosphorylation sites on the TrkB receptor tyrosine kinase by site-directed mutagenesis. , 1994, The Journal of biological chemistry.

[62]  M. Karayiorgou,et al.  Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. , 2003, American journal of human genetics.

[63]  P. Worley,et al.  Coupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins , 1999, Neuron.

[64]  T. Renné,et al.  Identification of SPRED2 (Sprouty-related Protein with EVH1 Domain 2) as a Negative Regulator of the Hypothalamic-Pituitary-Adrenal Axis* , 2011, The Journal of Biological Chemistry.

[65]  M. Yekezare,et al.  Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling , 2009, The Journal of cell biology.

[66]  R. Baron,et al.  Spred is a Sprouty-related suppressor of Ras signalling , 2001, Nature.

[67]  Dan J Stein,et al.  Should OCD be classified as an anxiety disorder in DSM‐V? , 2010, Depression and anxiety.

[68]  Jesse Wood,et al.  A Framework for Understanding the Emerging Role of Corticolimbic-Ventral Striatal Networks in OCD-Associated Repetitive Behaviors , 2015, Front. Syst. Neurosci..

[69]  T. Renné,et al.  Expression and subcellular localization of Spred proteins in mouse and human tissues , 2004, Histochemistry and Cell Biology.

[70]  C. McDougle,et al.  Symptoms of obsessive-compulsive disorder. , 1997, The American journal of psychiatry.

[71]  L. Kruisselbrink,et al.  The Neurocognitive Effects of Alcohol Hangover: Patterns of Impairment/Nonimpairment Within the Neurocognitive Domains of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition , 2019, Neuroscience of Alcohol.

[72]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[73]  E. Cattaneo,et al.  Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.

[74]  A. Oliveira-Maia,et al.  Brain-derived neurotrophic factor: a biomarker for obsessive-compulsive disorder? , 2015, Front. Neurosci..

[75]  T. Renné,et al.  Gene Disruption of Spred-2 Causes Dwarfism* , 2005, Journal of Biological Chemistry.

[76]  Haiqun Lin,et al.  Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents ith Tourette's syndrome and obsessive-compulsive disorder. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[77]  P. Conn,et al.  Metabotropic glutamate receptors: physiology, pharmacology, and disease. , 2010, Annual review of pharmacology and toxicology.

[78]  K. Giese,et al.  The roles of protein kinases in learning and memory. , 2013, Learning & memory.

[79]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[80]  J. Scharf,et al.  Genetics of obsessive-compulsive disorder and related disorders. , 2014, The Psychiatric clinics of North America.